Management of diabetes: Are doctors framing the benefits from the wrong perspective?

BMJ

Volumn 323, Issue 7319, 2001, Pages 994-996

  Wolpert, Howard A ^a   Anderson, Barbara J ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GLUCOSE MONITORING; COST BENEFIT ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; HUMAN; PATIENT CARE; PRIORITY JOURNAL; SELF MONITORING; SHORT SURVEY; TREATMENT PLANNING;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE MANAGEMENT; HUMANS; PATIENT EDUCATION; PATIENT-CENTERED CARE; QUALITY OF LIFE;

EID: 0035960282     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.323.7319.994     Document Type: Article

References (23)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 354: 837–853.
3. Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA 1996; 276: 1409–1415.
4. Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). BMJ 2000; 320: 1373–1378.
5. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381–389.
6. Clement S. Diabetes self-management education. Diabetes Care 1995; 18: 1204–1214.
7. Galazka SS, Eckert JK. Diabetes mellitus from the inside out: ecological perspectives on a chronic disease. Family Systems Medicine 1984; 2(1):28–36.
8. Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC. Patient empowerment: results of a randomized controlled trial. Diabetes Care 1995; 18: 943–949.
9. Williams GC, Freedman ZR, Deci EL. Supporting autonomy to motivate patients with diabetes to glucose control. Diabetes Care 1998; 21: 1644–1651.
10. Greenfield S, Kaplan SH, Ware JE, Yano EM, Frank HJL. Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Int Med 1988; 3: 448–457.
11. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness. Ann Intern Med 1997; 127: 1097–1102.
12. Rollnick S, Kinnersley P, Stott N. Methods of helping patients with behaviour change. BMJ 1993; 307: 188–190.
13. Rollnick S, Mason P, Butler C. Health behaviour change: a guide for practitioners. Edinburgh: Churchill Livingstone, 1999.
14. Wolpert HA, Anderson BJ. Metabolic control matters. Why is the message lost in the translation? The need for realistic goal-setting in diabetes care. Diabetes Care 2001; 24: 1301–1303.
15. Diabetes UK. Recommendations for the management of diabetes in primary care. London: Diabetes UK, 2000
16. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2001; 24(suppl1):S33–S43.
17. Miller WR, Rollnick S. Motivational interviewing. New York: Guilford Press, 1991.
18. American Diabetes Association. American Diabetes Association complete guide to diabetes: the ultimate home diabetes reference. 2nd ed. Alexandria, VA: ADA, 1999.
19. Coyne JC, Wortman C, Lehman D. The other side of support: emotional overinvolvement and miscarried helping. In: Gottlieb BH,ed. Marshalling social support: formats, processes and effects. Newbury Park, CA: Sage, 1988: 309–330.
20. Anderson BJ. Working with families of patients on intensive insulin regimens. Diabetes Spectrum 1995; 8: 69–70.
21. Howorka K, Pumpria J, Wagner-Nosiska D, Grillmayr H, Schlusche C, Schabmann A. Empowering diabetes out-patients with structured education: short-term and long-term effects of functional insulin treatment on perceived control over diabetes. J Psychosom Res 2000; 48: 37–44.
22. Bott S, Bott U, Berger M, Mulhauser I. Intensified insulin therapy and the risk of severe hypoglycemia. Diabetologia 1997; 40: 926–932.
23. DAFNE Study Group. DAFNE (dosage adjustment for normal eating) methodology and quality assurance for exploratory trial. Diabet Med 2001; 18(suppl 2):325.